The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000206.3(IL2RG):c.545G>A (p.Cys182Tyr)

CA16621484

419664 (ClinVar)

Gene: IL2RG (HGNC:3561)
Condition: T-B+ severe combined immunodeficiency due to gamma chain deficiency (MONDO:0010315)
Inheritance Mode: X-linked inheritance
UUID: 1999996a-5910-405a-bb2e-51c3ec48dcce
Approved on: 2024-01-10
Published on: 2024-01-10

HGVS expressions

NM_000206.3(IL2RG):c.545G>A (p.Cys182Tyr)
NM_000206.3:c.545G>A
NC_000023.11:g.71110205C>T
CM000685.2:g.71110205C>T
NC_000023.10:g.70330055C>T
CM000685.1:g.70330055C>T
NC_000023.9:g.70246780C>T
NG_009088.1:g.6349G>A
NG_021141.1:g.1584G>A
ENST00000374202.7:c.545G>A
ENST00000642473.1:n.909G>A
ENST00000644022.1:n.860+299G>A
ENST00000644708.1:n.951G>A
ENST00000644911.1:n.951G>A
ENST00000645266.1:c.545G>A
ENST00000645518.1:c.545G>A
ENST00000646106.1:c.545G>A
ENST00000646505.1:c.545G>A
ENST00000647492.1:c.545G>A
ENST00000276110.6:n.1138G>A
ENST00000374188.7:c.-172G>A
ENST00000374202.6:c.545G>A
ENST00000456850.6:c.25-815G>A
ENST00000464642.5:c.413G>A
ENST00000487883.1:c.509G>A
ENST00000512747.3:n.521+299G>A
NM_000206.2:c.545G>A
More

Likely Pathogenic

Met criteria codes 3
PS4 PP4_Moderate PM2_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Severe Combined Immunodeficiency Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for IL2RG Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Severe Combined Immunodeficiency Disease VCEP
NM_000206.3(IL2RG):c.545G>A is a missense variant predicted to cause substitution of Cysteine by Tyrosine at amino acid 182 (p.Cys182Tyr). The variant is absent in gnomAD v4 (PM2_supporting). Male patient (0.5 pt.) with SCID (0.5 pt.), genome sequencing conducted (1 pt.),Reduced IL2-induced phosphorylation of STAT5 (1 pt.), T-B+NK- lymphocyte subset profile (0.5 pt.); total :3.5 pts (PP4_Moderate) PMID: 18688286. This variant has been reported in 6 probands (PS4_met, 5pts)(PMIDs: 25109802,22039266,18688286,35482138, 21865537,18728247) Another missense variant Cys182Arg in the same codon has been reported (PMID: 10794430) (not classified by SCID VCEP yet) (PM5 not evaluated). In summary, this variant meets the criteria to be classified as a Likely Pathogenic variant for X-linked severe combined immunodeficiency due to IL2RG deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP: PM2_supporting,PP4_Moderate, PS4_met(VCEP specifications version 1).
Met criteria codes
PS4
This variant has been reported in 6 probands (PS4_met, 5pts)(PMIDs: 25109802,22039266,18688286,35482138, 21865537,18728247)
PP4_Moderate
Male patient (0.5 pt.) with SCID (0.5 pt.), genome sequencing conducted (1 pt.),Reduced IL2-induced phosphorylation of STAT5 (1 pt.), T-B+NK- lymphocyte subset profile (0.5 pt.); total :3.5 pts (PP4_Moderate) (PMID: 18688286).
PM2_Supporting
The variant is absent in gnomAD v4 (PM2_supporting).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.